PACS
PACS Group, Inc. · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth +5.9% ·
share flow -6.1% ·
net new positions 0.0%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 8.23K | $359,810 | n/a | n/a |
| Q2 2026 | 92 | +6 | 32.30M | $1.38B | +8 | −2 |
| Q1 2026 | 89 | +3 | 29.37M | $943.57M | +9 | −6 |
| Q4 2025 | 86 | +1 | 29.12M | $1.12B | +1 | n/a |
| Q3 2025 | 18 | +1 | 20.54M | $282.02M | +1 | −1 |
| Q2 2025 | 15 | 0 | 21.01M | $271.39M | +2 | −2 |
| Q1 2025 | 12 | +1 | 9.60M | $107.95M | +2 | −1 |
| Q4 2024 | 11 | -2 | 10.08M | $132.14M | +2 | −4 |
| Q3 2024 | 12 | +1 | 9.71M | $388.06M | +1 | n/a |
| Q2 2024 | 11 | n/a | 6.66M | $196.56M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 5.06M | +32.6% | $69.44M | 0.0% | ▲ Add | 2 | SEC ↗ ×14 |
| 2 | Fidelity (FMR) ✦ | 4.95M | +36.5% | $67.97M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 3 | The Vanguard Group ✦ (passive) | 3.94M | +2.2% | $54.09M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | Wellington Management ✦ | 1.54M | -76.4% | $21.09M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 5 | Marshall Wace ✦ | 1.01M | +348.6% | $13.88M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 6 | Geode Capital Management ✦ (passive) | 996.55K | +4.6% | $13.68M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | State Street Global Advisors ✦ (passive) | 984.13K | +5.3% | $13.51M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 497.84K | n/a | $6.84M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 9 | Citadel Advisors ✦ | 374.04K | +5.5% | $5.14M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 310.31K | n/a | $4.26M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 243.12K | +18.5% | $3.34M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Millennium Management ✦ | 206.66K | +18.1% | $2.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 122.55K | -24.7% | $1.68M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 14 | D. E. Shaw & Co. ✦ | 95.96K | New | $1.32M | 0.0% | New | 1 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 89.80K | -13.6% | $1.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 73.49K | n/a | $1.01M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 17 | Arrowstreet Capital ✦ | 26.98K | -40.6% | $370,394 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 23.36K | +6.0% | $321,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $1.32M | 0.0% |
Exited
| Norges Bank | $200,570 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 9.10K shares, $292 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director, 10% owner · 8.46K sh · $402,876
Officer, Director, 10% owner · 4.63K sh · $211,319
Officer, Director, 10% owner · 3.06K sh · $147,298
Officer, Director, 10% owner · 77.54K sh · $3.68M
Officer, Director, 10% owner · 24.80K sh · $1.16M
Officer · 40.00K sh · $1.78M
Officer, Director, 10% owner · 232 sh · $10,440
Officer, Director, 10% owner · 717 sh · $30,458
Officer, Director, 10% owner · 7.22K sh · $315,146
Officer, Director, 10% owner · 28.75K sh · $1.24M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology